NaDeNo seeks funding ahead of clinical entry

Nordic Life Science Days

With a base at AstraZeneca’s BioVentureHub, NaDeNo Nanoscience was on home turf when Nordic Life Science Days brought the industry together.

“It’s an exciting stage for the company as the technology moves from preclinical to clinical development,” say Annbjørg Eide Falck and Jens Bjørheim from NaDeNo Nanoscience.

NaDeNo at Nordic Lfe Science Days 2025

October 23, 2025

Share on: